Papers by Jacqueline Filshie
Acupuncture in Medicine, 1984
Complementary Therapies in Medicine, Dec 1, 2001
Palliative Medicine, 1988
The history of acupuncture is described up to the present day. The different methods are explaine... more The history of acupuncture is described up to the present day. The different methods are explained and both empirical and controlled studies on acupuncture are reviewed. The neurophysiology and neuropharmacology of acupuncture are discussed, including the contribution of endorphins.
Churchill Livingstone eBooks, 1998
Palliative Medicine, Apr 1, 1996
CRC Press eBooks, Apr 28, 2004
PubMed, Nov 1, 1986
We describe the first use of Hickman-Broviac catheters in 20 children under the age of 4 years fo... more We describe the first use of Hickman-Broviac catheters in 20 children under the age of 4 years for repeated daily general anaesthesia for radiotherapy. These children received a total of four hundred and eighty two general anaesthetics. The advantages and disadvantages of using Hickman-Broviac lines are discussed.
Ejc Supplements, Oct 1, 2005
Acupuncture in Medicine, Aug 1, 2002
European Journal of Cancer, Aug 1, 2006
Acupuncture in Medicine, Sep 1, 2004
Anesthesia & Analgesia, 1998
Acupuncture in Medicine, Sep 1, 2011
Palliative Medicine, Dec 1, 2003
Complementary medicine is fast becoming an integral part of palliative cancer care. There is cons... more Complementary medicine is fast becoming an integral part of palliative cancer care. There is considerable debate as to whether such treatments require proof of effectiveness through randomized clinical trials or whether it may suffice that patients adopt them with apparent appreciation. We attempt to raise some of the arguments on both sides. The arguments include the logistical problems of conducting research in palliative care, ethical problems of placebo controls, methodological difficulties of standardizing treatments or quantifying subtle effects and the, often considerable, costs of clinical trials. We feel that neither those who argue against nor those who argue in favour of rigorous clinical trials are entirely wrong or entirely right. However, our final verdict is that an absence of rigorous science will critically hinder progress. This, in turn, would be to the detriment of future patients. Through discussing the strengths and weaknesses of both sets of arguments, both sides might learn valuable lessons.
Uploads
Papers by Jacqueline Filshie